Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for recurrence and survival in stage II-III colon cancer
NL-OMON58621Phase 3Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Aug 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in colon cancer comparing Aspirin with Placebo (2 arms). Primary endpoint: 5-year overall survival. Started Aug 2014; status: active, not recruiting.
02
Drugs
aspirin
03
Conditions
colon cancer
Beyond the preview
Go deeper on NL-OMON58621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58621.